Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Asad

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
JMIR Research Protocols|February 13, 2020
Identifying Barriers and Enablers to Attending Diabetic Retinopathy Screening in Immigrants to Canada From Ethnocultural Minority Groups: Protocol for a Qualitative Descriptive StudyMaman Joyce Dogba, Michael H Brent, Catherine Bach, et al.
Breast Cancer Research : BCR|November 15, 2022
Association of body mass index and inflammatory dietary pattern with breast cancer pathologic and genomic immunophenotype in the nurses' health studySarah Asad, Adrienne Damicis, Yujing J Heng, et al.
JCO Oncology Practice|October 21, 2025
Impact of an Electronic Patient-Reported Outcome-Informed Clinical Decision Support Tool on Clinical Discussions With Head and Neck Cancer Survivors: Findings From the HN-STAR Randomized Controlled Trial (WF-1805CD)Talya Salz, Emily V Dressler, Carol Kittel, et al.
Genome Medicine|May 21, 2021
Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancerZachary T Weber, Katharine A Collier, David Tallman, et al.
JAMA Oncology|February 18, 2021
Association of Immunophenotype With Pathologic Complete Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Secondary Analysis of the BrighTNess Phase 3 Randomized Clinical TrialOtto Metzger Filho, Daniel G Stover, Sarah Asad, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 17, 2020
Barriers to and enablers of attendance at diabetic retinopathy screening experienced by immigrants to Canada from multiple cultural and linguistic minority groupsZack van Allen, Maman Joyce Dogba, Michael H Brent, et al.
BMC Cancer|May 8, 2020
Metastatic breast cancer patient perceptions of somatic tumor genomic testingElizabeth J Adams, Sarah Asad, Raquel Reinbolt, et al.
NPJ Breast Cancer|November 12, 2021
Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightnessOtto Metzger-Filho, Katharine Collier, Sarah Asad, et al.
JCO Precision Oncology|September 14, 2020
Prospective Decision Analysis Study of Clinical Genomic Testing in Metastatic Breast Cancer: Impact on Outcomes and Patient PerceptionsDaniel G Stover, Raquel E Reinbolt, Elizabeth J Adams, et al.
NAR Cancer|June 23, 2022
Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy responseKevin J Thompson, Roberto A Leon-Ferre, Jason P Sinnwell, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
JMIR Research Protocols|February 13, 2020
Identifying Barriers and Enablers to Attending Diabetic Retinopathy Screening in Immigrants to Canada From Ethnocultural Minority Groups: Protocol for a Qualitative Descriptive StudyMaman Joyce Dogba, Michael H Brent, Catherine Bach, et al.
Breast Cancer Research : BCR|November 15, 2022
Association of body mass index and inflammatory dietary pattern with breast cancer pathologic and genomic immunophenotype in the nurses' health studySarah Asad, Adrienne Damicis, Yujing J Heng, et al.
JCO Oncology Practice|October 21, 2025
Impact of an Electronic Patient-Reported Outcome-Informed Clinical Decision Support Tool on Clinical Discussions With Head and Neck Cancer Survivors: Findings From the HN-STAR Randomized Controlled Trial (WF-1805CD)Talya Salz, Emily V Dressler, Carol Kittel, et al.
Genome Medicine|May 21, 2021
Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancerZachary T Weber, Katharine A Collier, David Tallman, et al.
JAMA Oncology|February 18, 2021
Association of Immunophenotype With Pathologic Complete Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Secondary Analysis of the BrighTNess Phase 3 Randomized Clinical TrialOtto Metzger Filho, Daniel G Stover, Sarah Asad, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 17, 2020
Barriers to and enablers of attendance at diabetic retinopathy screening experienced by immigrants to Canada from multiple cultural and linguistic minority groupsZack van Allen, Maman Joyce Dogba, Michael H Brent, et al.
BMC Cancer|May 8, 2020
Metastatic breast cancer patient perceptions of somatic tumor genomic testingElizabeth J Adams, Sarah Asad, Raquel Reinbolt, et al.
NPJ Breast Cancer|November 12, 2021
Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightnessOtto Metzger-Filho, Katharine Collier, Sarah Asad, et al.
JCO Precision Oncology|September 14, 2020
Prospective Decision Analysis Study of Clinical Genomic Testing in Metastatic Breast Cancer: Impact on Outcomes and Patient PerceptionsDaniel G Stover, Raquel E Reinbolt, Elizabeth J Adams, et al.
NAR Cancer|June 23, 2022
Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy responseKevin J Thompson, Roberto A Leon-Ferre, Jason P Sinnwell, et al.
Pageof 4